Issue No. 30

AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.

Need Drug Information? AIDSinfo Has You Covered in Both English and Spanish!

The AIDSinfo Drug Database is stocked with fact sheets on more than 80 HIV/AIDS- related drugs. The fact sheets (in patient, health professional, and Spanish versions) describe the drug's use, pharmacology, side effects, and a wealth of other information. The database also includes approved and investigational antiretroviral drugs as well as drugs used in the treatment of opportunistic infections and cancers.

Newly added fact sheets include:

• Prezista, a recently approved protease inhibitor
• Atripla, the first one-pill, once-a-day treatment for HIV

FDA Notice Regarding Faulty HIV-1 Test Kit
On July 26, 2006, the Food and Drug Administration (FDA) announced that bioMerieux, Inc., the manufacturer of Vironostika HIV-1 testing kits, reported that five of their diagnostic testing kit lots “contain EnzAbody reagent that appears noticeably cloudy and/or flocculent, instead of clear and non-turbid as expected 30 minutes after reconstitution.”

Kit lot numbers identified are: 121566, 121567, 121568, 160342, and 160339 with EnzAbody Lot Numbers: 1008926, 1008926, 1008926, 1011220, and 1011021, respectively.